Position in GILD
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$93,191,283
+$38,921,670 QoQ
Shares Held
668,661
+51.2% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026FIFTH THIRD BANCORP holds $3,423,078,141 across 17 Drug Manufacturers - General names. GILD ranks #7 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,963,490 | $1,805,959,197 | |
| 2 | JNJ |
Johnson & Johnson
|
1,969,767 | $481,489,845 | |
| 3 | ABBV |
AbbVie Inc.
|
2,197,894 | $478,019,966 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,543,397 | $185,655,225 | |
| 5 | AMGN |
Amgen Inc
|
461,207 | $162,275,682 | |
| 6 | PFE |
Pfizer Inc
|
4,536,233 | $127,377,422 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
668,661 | $93,191,283 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,191,379 | $72,257,136 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $93,191,283 | 668,661 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $54,269,613 | 442,151 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $43,685,715 | 393,565 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $42,011,193 | 378,923 | Shares | Defined | 2025-07-15 | |
| 2025-03-31 | $41,357,767 | 369,101 | Shares | Defined | 2025-04-15 | |
| 2024-12-31 | $27,073,092 | 293,094 | Shares | Defined | 2025-01-21 | |
| 2024-09-30 | $24,621,125 | 293,668 | Shares | Defined | 2024-10-17 | |
| 2024-06-30 | $20,402,075 | 297,363 | Shares | Defined | 2024-07-22 | |
| 2024-03-31 | $23,430,404 | 319,869 | Shares | Defined | 2024-04-23 | |
| 2023-12-31 | $26,341,211 | 325,160 | Shares | Defined | 2024-01-19 | |
| 2023-09-30 | $24,628,281 | 328,640 | Shares | Defined | 2023-10-31 | |
| 2023-06-30 | $26,249,271 | 340,590 | Shares | Defined | 2023-07-26 | |
| 2023-03-31 | $28,834,978 | 347,535 | Shares | Defined | 2023-04-24 | |
| 2022-12-31 | $31,629,200 | 368,424 | Shares | Defined | 2023-01-25 | |
| 2022-09-30 | $23,187,975 | 375,879 | Shares | Defined | 2022-10-25 | |
| 2022-06-30 | $22,826,247 | 369,297 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $22,772,560 | 383,054 | Shares | Defined | 2022-04-19 | |
| 2021-12-31 | $29,036,303 | 399,894 | Shares | Defined | 2022-02-01 | |
| 2021-09-30 | $28,153,880 | 403,062 | Shares | Defined | 2021-10-15 | |
| 2021-06-30 | $26,953,525 | 391,425 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $26,761,020 | 414,065 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $24,578,262 | 421,872 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $32,821,960 | 519,417 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $41,925,837 | 544,916 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $41,841,527 | 559,678 | Shares | Defined | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||